Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

101. Women’s health and midwifery: Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Full Text available with Trip Pro

Women’s health and midwifery: Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie (...) behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Article Text Commentary Women’s health and midwifery Training health visitors in cognitive behavioural or person-centred approaches is cost-effective and can improve outcomes for women at risk of postnatal depression Ben Parkinson , Emma MacDonald Statistics from Altmetric.com Commentary on: Henderson C, Dixon S, Bauer A. et al . Cost-Effectiveness of PoNDER Health Visitor Training

2019 Evidence-Based Nursing

102. Psychological interventions: Preventive cognitive therapy could be a viable and effective addition to antidepressant medication in preventing relapse or recurrence in major depressive disorder

Psychological interventions: Preventive cognitive therapy could be a viable and effective addition to antidepressant medication in preventing relapse or recurrence in major depressive disorder Preventive cognitive therapy could be a viable and effective addition to antidepressant medication in preventing relapse or recurrence in major depressive disorder | Evidence-Based Mental Health Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Preventive cognitive therapy could be a viable and effective addition to antidepressant medication in preventing relapse or recurrence in major depressive disorder Article Text Commentary Psychological interventions Preventive cognitive therapy

2019 Evidence-Based Mental Health

103. Perinatal Depression: Preventive Interventions

Perinatal Depression: Preventive Interventions Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Pregnant and postpartum persons The USPSTF recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions. B View the Clinical Summary in Population Pregnant and postpartum persons Recommendation Provide or refer persons at increased (...) risk of perinatal depression to counseling interventions. Grade: B Risk Assessment There is no accurate screening tool for identifying who is at risk of perinatal depression and who might benefit from preventive interventions. A pragmatic approach, based on the populations included in the systematic evidence review, would be to provide counseling interventions to women with 1 or more of the following risk factors: a history of depression, current depressive symptoms (that do not reach a diagnostic

2019 U.S. Preventive Services Task Force

104. Care of the older person: Evidence that active pain treatment improves sleep quality and quantity in people with depression and dementia Full Text available with Trip Pro

Care of the older person: Evidence that active pain treatment improves sleep quality and quantity in people with depression and dementia Evidence that active pain treatment improves sleep quality and quantity in people with depression and dementia | Evidence-Based Nursing Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Evidence that active pain treatment improves sleep quality and quantity in people with depression and dementia Article Text Commentary Care of the older person Evidence that active pain treatment improves sleep quality and quantity in people with depression and dementia Amelia Swift Statistics from Altmetric.com Commentary on : Blytt KM, Bjorvatn B, Husebo B

2019 Evidence-Based Nursing

105. Adult nursing: Higher rates of depression among women living with Coronary Heart Disease are associated with poorer treatment outcomes and prognosis

Adult nursing: Higher rates of depression among women living with Coronary Heart Disease are associated with poorer treatment outcomes and prognosis Higher rates of depression among women living with Coronary Heart Disease are associated with poorer treatment outcomes and prognosis | Evidence-Based Nursing Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Higher rates of depression among women living with Coronary Heart Disease are associated with poorer treatment outcomes and prognosis Article Text Commentary Adult nursing Higher rates of depression among women living with Coronary Heart Disease are associated with poorer treatment outcomes and prognosis Karen McGuigan

2019 Evidence-Based Nursing

106. Depression Following Acute Coronary Syndrome

Depression Following Acute Coronary Syndrome Depression Following Acute Coronary Syndrome -- Clinical Recommendation Welcome Search Search Specify your search AAFP.org Patient Care Clinical Practice Guideline Depression Following Acute Coronary Syndrome Screening and Treatment of Depression Following Acute Coronary Syndrome (Developed by the AAFP, March 2019) The guideline, Screening and Treatment of Depression Following Acute Coronary Syndrome , was developed by the American Academy of Family (...) Physicians and approved by the Board of Directors in March 2019. The guideline was published in the American Family Physician on June 14, 2019. Key Recommendations A standardized depression screening tool (e.g. BDI-II, HADS, GDS, PHQ) should be used to screen for depression in patients who have recently experienced an acute coronary syndrome (ACS) event. In patients who screen positive for depression, further assessment should be performed to confirm the diagnosis of depression Antidepressant medication

2019 American Academy of Family Physicians

107. Management of Major Depressive Disorder (2nd Ediiton)

Management of Major Depressive Disorder (2nd Ediiton) MOH/P/PAK/423.19(GU)-e 2019 CLINICAL PRACTICE GUIDELINES 2019 MOH/P/PAK/423.19(GU)-e Management of Major Depressive Disorder (Second Edition) Published by: Malaysian Health Technology Assessment Section (MaHTAS) Medical Development Division, Ministry of Health Malaysia Level 4, Block E1, Precinct 1 Federal Government Administrative Centre 62590 Putrajaya, Malaysia Copyright The copyright owner of this publication is MaHTAS. Content may (...) OF INTENT These clinical practice guidelines (CPG) are meant to be guides for clinical practice, based on the best available evidence at the time of development. Adherence to these guidelines may not necessarily guar- antee the best outcome in every case. Every healthcare provider is responsible for the management of his/her unique patient based on the clinical picture presented by the patient and the management options available locally. Management of Major Depressive Disorder (Second Edition) UPDATING

2019 Ministry of Health, Malaysia

108. The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review Full Text available with Trip Pro

The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review - Murray - 2019 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access The impact of care farms (...) on quality of life, depression and anxiety among different population groups: A systematic review Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Plant Research International, Wageningen University, Wageningen, The Netherlands Care Farming UK, Bedminster, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK

2019 Campbell Collaboration

109. A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms. Full Text available with Trip Pro

A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms. S47445 is a novel positive allosteric modulator of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors that may emerge as a favorable candidate for the symptomatic treatment of cognitive and depressive disorders in patients suffering from Alzheimer's disease (AD) of mild to moderate severity (...) and with depressive symptoms.For this double-blind, placebo-controlled 24-week phase II trial, 520 outpatients aged between 55 and 85 years, with probable AD at mild to moderate stages (a Mini-Mental State Examination score of 24-15 inclusive) and exhibiting depressive symptoms (Cornell Scale for Depression in Dementia [CSDD] ≥ 8) were recruited in twelve countries and randomized to 3 doses of S47445 (5-15-50 mg) or placebo. The primary end point was the change from baseline in the 11-item Alzheimer's Disease

2019 Alzheimer's & dementia (New York, N. Y.) Controlled trial quality: predicted high

110. Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. Full Text available with Trip Pro

Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. Refractory depression is a major contributor to the economic burden of depression. Radically open dialectical behaviour therapy (RO DBT) is an unevaluated new treatment targeting overcontrolled personality, common in refractory depression, but it is not yet known whether the additional expense of RO DBT is good value for money.AimsTo estimate the cost (...) -effectiveness of RO DBT plus treatment as usual (TAU) compared with TAU alone in people with refractory depression (trial registration: ISRCTN85784627).We undertook a cost-effectiveness analysis alongside a randomised trial evaluating RO DBT plus TAU versus TAU alone for refractory depression in three UK secondary care centres. Our economic evaluation, 12 months after randomisation, adopted the perspective of the UK National Health Service (NHS) and personal social services. It evaluated cost-effectiveness

2019 BJPsych open Controlled trial quality: uncertain

111. Stepped care programme in primary care to prevent anxiety and depression: a randomised clinical trial. (Abstract)

Stepped care programme in primary care to prevent anxiety and depression: a randomised clinical trial. 30792364 2019 11 20 1024-2708 25 Suppl 3 1 2019 Feb Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Stepped care programme in primary care to prevent anxiety and depression: a randomised clinical trial. 9-10 Wong S Ys SY The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong. Tang W K WK Department of Psychiatry, Faculty of Medicine

2019 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: uncertain

112. Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial. Full Text available with Trip Pro

Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial. A third of patients diagnosed with major depressive disorder (MDD) experience treatment-resistant depression (TRD). Relatively few pharmacological agents have established efficacy for TRD. Therefore, the evaluation of novel treatments for TRD is a pressing priority. Statins are pleiotropic agents and preclinical studies as well as preliminary clinical trials have suggested (...) will receive simvastatin and 75 patients will receive placebo as adjuncts to treatment as usual. The primary outcome is change in Montgomery-Åsberg Depression Rating Scale scores from baseline to week 12 and secondary outcomes include changes in scores on the 24-item Hamilton Rating Scale for Depression, the Clinical Global Impression scale, the 7-item Generalized Anxiety Disorder scale and change in body mass index from baseline to week 12. Assessments will take place at screening, baseline, and weeks 2

2019 BJPsych open Controlled trial quality: predicted high

113. Depression in children

Depression in children Depression in children - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Depression in children Last reviewed: February 2019 Last updated: December 2018 Summary Characterised by sad or irritable mood, anhedonia, decreased capacity to have fun, decreased self-esteem, sleep disturbance, social withdrawal or impaired social relationships, and impaired school performance. One of the most common (...) paediatric psychiatric disorders, especially among girls during adolescence. At-risk children should be screened for depression. It is crucial to make an accurate diagnosis, based on a comprehensive assessment and review of the history, with input from multiple sources. The safety of the child and others, and the duration and severity of depression, need to be evaluated carefully to help determine the appropriate level of care and treatment modality. Treatment is typically with active monitoring

2018 BMJ Best Practice

114. Brief integrated sleep-focused treatment for persistent sleep disturbance in residual depression: an assessor-blind, parallel group, randomised controlled study. (Abstract)

Brief integrated sleep-focused treatment for persistent sleep disturbance in residual depression: an assessor-blind, parallel group, randomised controlled study. 29938650 2018 12 11 2018 12 11 1024-2708 24 Suppl 2 1 2018 02 Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Brief integrated sleep-focused treatment for persistent sleep disturbance in residual depression: an assessor-blind, parallel group, randomised controlled study. 8-11 Wing Y K YK Department of Psychiatry (...) , The Chinese University of Hong Kong. Li A M AM Department of Paediatrics, The Chinese University of Hong Kong. Lam J Sp JS Department of Psychiatry, The Chinese University of Hong Kong. Li S X SX Department of Psychology, The University of Hong Kong. Kwok A Pl AP Department of Clinical Psychology, New Territories East Cluster, Hospital Authority. eng Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't China Hong Kong Med J 9512509 1024-2708 IM Adult Depressive Disorder, Major

2018 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: uncertain

115. Got Depression? I can answer that in two questions!

Got Depression? I can answer that in two questions! Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca January 15, 2018 (...) Got Depression? I can answer that in two questions! Clinical Question: What is the diagnostic accuracy of the 2-question screen for identifying depression in primary care? Bottom Line: The 2-question screen is good at ruling out (but not ruling in) depression in primary care. Up to 50% of patients will test positive and should have more thorough evaluation to confirm depression diagnosis. Whether screening alters outcomes is debatable, but the 2-question screen may be reasonable for case- finding

2018 Tools for Practice

116. St. John?s Wort for Depression: Flower Power?

St. John?s Wort for Depression: Flower Power? Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca March 12, 2018 St. John (...) ’s Wort for Depression: Flower Power? Clinical Question: Is St. John ’s Wort (SJW) an option for treating mild-moderate depression? Bottom Line: In mild-moderate depression, SJW may improve depression scores and have response or remission rates similar to antidepressants, with fewer reported adverse effects. The evidence is potentially limited by studies of short duration, funding by SJW manufacturers, and inadequately described methods. SJW may be an option for patients experiencing mild

2018 Tools for Practice

117. Effect of a Lay Counselor Intervention on Prevention of Major Depression in Older Adults Living in Low- and Middle-Income Countries: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of a Lay Counselor Intervention on Prevention of Major Depression in Older Adults Living in Low- and Middle-Income Countries: A Randomized Clinical Trial Preventing depression in older adults living in low- and middle-income countries is important because of the scarcity of treatment resources and the risk of disability, suicide, and dementia.To assess whether an intervention for depression prevention provided by lay counselors is effective in older adults from low- and middle-income (...) countries.This parallel-group randomized clinical trial with masked outcome assessment was performed in 181 older adults (≥60 years) with subsyndromal depressive symptoms at rural and urban primary care clinics in Goa, India. The first participant entered the trial on March 31, 2015, and the last exited on June 2, 2017. Data analysis used the intention-to-treat approach.Lay counselors provided problem-solving therapy, brief behavioral treatment for insomnia, education in self-care of common medical disorders

2018 EvidenceUpdates

118. Overview of depression

Overview of depression Overview of depression - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of depression Last reviewed: February 2019 Last updated: November 2018 Introduction Depression is a mental state characterised by persistent low mood, loss of interest and enjoyment in everyday activities, neurovegetative disturbance, and reduced energy, causing varying levels of social and occupational dysfunction (...) . Depressive disorders are common in people of all ages and may be classified depending on the duration, severity, and number of symptoms, and the degree of functional impairment. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. (DSM-5). Washington, DC: American Psychiatric Publishing; 2013. In bipolar disorder, a manic episode may have been preceded by and may be followed by hypomanic or major depressive episodes. American Psychiatric Association. Diagnostic

2018 BMJ Best Practice

119. Impact of resilience on the improvement of depressive symptoms after cognitive therapies for depression in a sample of young adults. Full Text available with Trip Pro

Impact of resilience on the improvement of depressive symptoms after cognitive therapies for depression in a sample of young adults. Few studies have evaluated positive measures for therapeutic response. Thus, the objective of this study was to assess the effects of resilience on severity of depressive and anxious symptoms after brief cognitive psychotherapy for depression.This was a clinical follow-up study nested in a randomized clinical trial of cognitive therapies. The Resilience Scale (...) was applied at baseline. The Hamilton Anxiety Rating Scale (HARS) and the Hamilton Depression Rating Scale (HDRS) were used at baseline, post-intervention, and at six-month follow-up.Sixty-one patients were assessed at baseline, post-intervention and at six-month follow-up. Resilience scores were significantly different between baseline and post-intervention assessments (p<0.001), as well as at baseline and at six-month follow-up (p<0.001). We observed a weak negative correlation between baseline

2018 Trends in psychiatry and psychotherapy Controlled trial quality: uncertain

120. Depression. (Abstract)

Depression. Major depression is a common illness that severely limits psychosocial functioning and diminishes quality of life. In 2008, WHO ranked major depression as the third cause of burden of disease worldwide and projected that the disease will rank first by 2030.1 In practice, its detection, diagnosis, and management often pose challenges for clinicians because of its various presentations, unpredictable course and prognosis, and variable response to treatment.Copyright © 2018 Elsevier

2018 Lancet